GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » Debt-to-Asset

Shanghai Haohai Biological Technology Co (SHSE:688366) Debt-to-Asset : 0.06 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Debt-to-Asset?

Shanghai Haohai Biological Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥231 Mil. Shanghai Haohai Biological Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥193 Mil. Shanghai Haohai Biological Technology Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was ¥7,242 Mil. Shanghai Haohai Biological Technology Co's debt to asset for the quarter that ended in Jun. 2024 was 0.06.


Shanghai Haohai Biological Technology Co Debt-to-Asset Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Debt-to-Asset Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.02 0.02 0.06

Shanghai Haohai Biological Technology Co Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.06 0.03 0.06 -

Competitive Comparison of Shanghai Haohai Biological Technology Co's Debt-to-Asset

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Debt-to-Asset falls into.



Shanghai Haohai Biological Technology Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Shanghai Haohai Biological Technology Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(216.625 + 191.324) / 7105.497
=0.06

Shanghai Haohai Biological Technology Co's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(230.989 + 193.191) / 7242.187
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haohai Biological Technology Co  (SHSE:688366) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Shanghai Haohai Biological Technology Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Executives
Tang Min Jie Directors, senior managers
Du Peng Core technical personnel
Hou Yong Tai Director, core technical staff
Jiang Li Xia Core technical personnel
Core technical personnel
Liu Lu Core technical personnel
Ren Cai Xia senior management
Wang Wen Bin Senior management, core technical personnel
Wu Jian Ying Directors, senior managers
Liu Yuan Zhong Supervisors
Huang Ming Director
Zhang Jun Dong Senior management, core technical personnel
You Jie Director
Tian Min senior management
Chen Yi Yi Director

Shanghai Haohai Biological Technology Co Headlines

No Headlines